Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 11335857Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Pharmacology
NIH Funding · FY2025
Linked Award Amount
$3.3M
Full award amounts, FY2025
Award Records
2
Records listing this PI
Award-Linked Rank
#2,847
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Fengtian Xue as a PI. Multi-PI records show the full award amount for context.
- 1R01CA295603-01A1R01Impact of CAR and Nrf2 dual activation on cyclophosphamide bioactivation and doxorubicin detoxification$2.8Maward amount
- 5R01DK133421-03R01Axin Stabilization by Novel Small Molecules to Treat Non-alcoholic Steatohepatitis$485.1Kaward amount
Award organization
Organizations that administered FY2025 awards listing Fengtian Xue as a PI.
FY2025 award administered by University of Maryland Baltimore (MD).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUniversity of Maryland Baltimore
- 2024$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2025$2M Cumulative Funding
- 2025Entered Top 50% NationallyRanked #2847
- 2025Entered Top 25% NationallyRanked #2847
- 2025R01 Grant Holder
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Fengtian Xue.